• DSM - delivery of shares 

    30 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares 

    29 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares 

    27 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares 

    23 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares 

    20 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares 

    19 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares 

    15 December 2022

    DSM - delivery of shares 

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

  • DSM - delivery of shares | DSM

    13 December 2022

    DSM - delivery of shares | DSM

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules.

  • DSM - delivery of shares | DSM

    6 December 2022

    DSM - delivery of shares | DSM

    Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules.

  • DSM starts construction of production facility for its novel Bovaer® methane-reducing feed in Dalry

    30 November 2022

    DSM starts construction of production facility for its novel Bovaer® methane-reducing feed in Dalry

    The plant will significantly increase global production of Bovaer®, DSM’s unique methane-reducing feed additive for cattle. In an official groundbreaking ceremony attended by the First Minister of Scotland, Nicola Sturgeon, and Dimitri de Vreeze, Co-CEO of DSM, the company marked the next step in its plan to use Bovaer® to reduce global methane emissions and contribute to worldwide methane reduction targets.

  • DSM provides Q3 2022 trading update | DSM

    1 November 2022

    DSM provides Q3 2022 trading update | DSM

    DSM’s trading update for the first nine months of 2022 is out now and our Health, Nutrition & Bioscience businesses all delivered good sales growth. Market demand remained resilient in what is a challenging macro-economic environment with the rising cost inflation.

  • DSM completes acquisition of Prodap

    1 September 2022

    DSM completes acquisition of Prodap

    DSM today announces the completion of its acquisition of Prodap, a leading animal nutrition and technology company in Brazil.

  • DSM announces sale of Engineering Materials business

    31 May 2022

    DSM announces sale of Engineering Materials business

    Royal DSM, a global purpose-led science-based company, today announces that it has reached an agreement to sell its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion.

  • DSM and the World Food Programme partner to improve nutrition around the world

    24 May 2022

    DSM and the World Food Programme partner to improve nutrition around the world

    Royal DSM and the World Food Programme (WFP) have agreed to extend their partnership and scale up rice fortification worldwide for a further three years. The partnership will seek to improve the availability and accessibility of nutritious foods in order to reach vulnerable people where key dietary decisions are made.

  • Final dividend 2021 Royal DSM | DSM

    10 May 2022

    Final dividend 2021 Royal DSM | DSM

    Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders.

  • DSM - repurchase of shares (25-29 April 2022)

    3 May 2022

    DSM - repurchase of shares (25-29 April 2022)

    Royal DSM, a global purpose-led science-based company, has repurchased 157,671 of its own shares in the period from 25 April 2022 up to and including 29 April 2022 at an average price of €156.34.

  • Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Additive for Cattle | DSM

    27 April 2022

    Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Additive for Cattle | DSM

    Elanco Animal Health Incorporated (ELAN: NYSE) and Royal DSM have created a strategic alliance connecting two leading, sustainability-focused companies to address one of society’s most significant opportunities of the decade, mitigating climate change by reducing greenhouse gas emissions from farming. Elanco has secured the exclusive U.S. licensing rights to develop, manufacture and commercialize Bovaer® for beef and dairy cattle.

  • DSM announces sale of Protective Materials business | DSM

    20 April 2022

    DSM announces sale of Protective Materials business | DSM

    Royal DSM, a global purpose-led science-based company, today announces that it has reached an agreement to sell its Protective Materials business to Avient Corporation for an Enterprise Value of €1.44 billion.

  • DSM provides preliminary 2021 comparative figures | DSM

    4 April 2022

    DSM provides preliminary 2021 comparative figures | DSM

    Royal DSM, a global purpose-led science-based company, today provides preliminary comparative financial figures for 2021 following the establishment of DSM’s Health, Nutrition & Bioscience (“HNB”) structure, which became effective as of 1 January 2022.

  • FrieslandCampina and DSM take major step to reduce greenhouse gas emissions from dairy cattle

    24 March 2022

    FrieslandCampina and DSM take major step to reduce greenhouse gas emissions from dairy cattle

    The Bovaer® pilot collaboration between the Dutch companies FrieslandCampina, DSM, and Agrifirm marks an important step forward in increasing the sustainability of the dairy sector. Some 200 FrieslandCampina dairy farms in the Netherlands will take part in the pilot in the second half of 2022. Providing the results are positive, the use of Bovaer® will be further upscaled from 2023.

  • DSM receives landmark EU market approval for its methane-reducing feed additive Bovaer®

    24 February 2022

    DSM receives landmark EU market approval for its methane-reducing feed additive Bovaer®

    Royal DSM, a global purpose-led science-based company, announces that European Union (EU) member states approved the marketing of the methane-reducing feed additive for dairy cows, Bovaer®, in the EU. After inclusion in the EU registry, expected in the coming weeks, it is the first time a feed additive authorised in the EU for environmental benefits can be marketed. This marks a significant milestone for DSM, paving the way for Bovaer® to revolutionize the dairy market.

  • DSM reports 2021 results | DSM

    15 February 2022

    DSM reports 2021 results | DSM

    Strong financial growth alongside significant progress toward our sustainability and strategy ambitions made 2021 a year to be proud of.